These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16699033)

  • 1. Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.
    Krause A; Joh JH; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG; Worgall S
    J Virol; 2006 Jun; 80(11):5523-30. PubMed ID: 16699033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.
    Sharma A; Krause A; Xu Y; Sung B; Wu W; Worgall S
    PLoS One; 2013; 8(2):e56996. PubMed ID: 23437292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid.
    Lanzi A; Ben Youssef G; Perricaudet M; Benihoud K
    Vaccine; 2011 Feb; 29(7):1463-71. PubMed ID: 21184856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
    Nanda A; Lynch DM; Goudsmit J; Lemckert AA; Ewald BA; Sumida SM; Truitt DM; Abbink P; Kishko MG; Gorgone DA; Lifton MA; Shen L; Carville A; Mansfield KG; Havenga MJ; Barouch DH
    J Virol; 2005 Nov; 79(22):14161-8. PubMed ID: 16254351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.
    Schoggins JW; Falck-Pedersen E
    J Virol; 2006 Nov; 80(21):10634-44. PubMed ID: 16943295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
    Matthews QL; Yang P; Wu Q; Belousova N; Rivera AA; Stoff-Khalili MA; Waehler R; Hsu HC; Li Z; Li J; Mountz JD; Wu H; Curiel DT
    Virol J; 2008 Aug; 5():98. PubMed ID: 18718011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy.
    Gu L; Krendelchtchikova V; Krendelchtchikov A; Farrow AL; Derdeyn CA; Matthews QL
    Virology; 2016 Jan; 487():75-84. PubMed ID: 26499044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.
    Shiratsuchi T; Rai U; Krause A; Worgall S; Tsuji M
    J Clin Invest; 2010 Oct; 120(10):3688-701. PubMed ID: 20811151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
    Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.
    Gu L; Farrow AL; Krendelchtchikov A; Matthews QL
    J Vis Exp; 2015 May; (99):e52655. PubMed ID: 25993057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral Responses Elicited by Adenovirus Displaying Epitopes Are Induced Independently of the Infection Process and Shaped by the Toll-Like Receptor/MyD88 Pathway.
    Anchim A; Raddi N; Zig L; Perrieau P; Le Goffic R; Ryffel B; Benihoud K
    Front Immunol; 2018; 9():124. PubMed ID: 29459860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
    Worgall S; Krause A; Qiu J; Joh J; Hackett NR; Crystal RG
    J Virol; 2007 Dec; 81(24):13801-8. PubMed ID: 17942539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico epitope prediction and immunogenic analysis for penton base epitope-focused vaccine against hydropericardium syndrome in chicken.
    Aziz F; Tufail S; Shah MA; Salahuddin Shah M; Habib M; Mirza O; Iqbal M; Rahman M
    Virus Res; 2019 Nov; 273():197750. PubMed ID: 31509776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
    Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
    J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.
    Tomita K; Sakurai F; Iizuka S; Hemmi M; Wakabayashi K; Machitani M; Tachibana M; Katayama K; Kamada H; Mizuguchi H
    Sci Rep; 2018 Aug; 8(1):12315. PubMed ID: 30120324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CryoEM visualization of an adenovirus capsid-incorporated HIV antigen.
    Flatt JW; Fox TL; Makarova N; Blackwell JL; Dmitriev IP; Kashentseva EA; Curiel DT; Stewart PL
    PLoS One; 2012; 7(11):e49607. PubMed ID: 23166728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.